1. A Comparison of Plasma Efavirenz and Tenofovir, Dried Blood Spot Tenofovir-Diphosphate, and Self-Reported Adherence to Predict Virologic Suppression Among South African Women. (1st July 2019) Authors: Phillips, Tamsin K.; Sinxadi, Phumla; Abrams, Elaine J.; Zerbe, Allison; Orrell, Catherine; Hu, Nai-Chung; Brittain, Kirsty; Gomba, Yolanda; Norman, Jennifer; Wiesner, Lubbe; Myer, Landon; Maartens, Gary Journal: Journal of acquired immune deficiency syndromes Issue: Volume 81:Number 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Concentration–response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy. Issue 3 (26th January 2022) Authors: Griesel, Rulan; Kawuma, Aida N.; Wasmann, Roeland; Sokhela, Simiso; Akpomiemie, Godspower; Venter, W. D. Francois; Wiesner, Lubbe; Denti, Paolo; Sinxadi, Phumla; Maartens, Gary Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 3(2022) Page Start: 883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. (31st January 2022) Authors: Griesel, Rulan; Maartens, Gary; Chirehwa, Maxwell; Sokhela, Simiso; Akpomiemie, Godspower; Moorhouse, Michelle; Venter, Francois; Sinxadi, Phumla Journal: Clinical infectious diseases Issue: Volume 74:Number 4(2022) Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. (22nd September 2020) Authors: Griesel, Rulan; Maartens, Gary; Chirehwa, Maxwell; Sokhela, Simiso; Akpomiemie, Godspower; Moorhouse, Michelle; Venter, Francois; Sinxadi, Phumla Journal: Clinical infectious diseases Issue: Volume 73:Number 11(2021) Page Start: e3902 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor–Containing Regimens. (17th October 2020) Authors: Leonard, Michael A; Cindi, Zinhle; Bradford, Yuki; Bourgi, Kassem; Koethe, John; Turner, Megan; Norwood, Jamison; Woodward, Beverly; Erdem, Husamettin; Basham, Rebecca; Baker, Paxton; Rebeiro, Peter F; Sterling, Timothy R; Hulgan, Todd; Daar, Eric S; Gulick, Roy; Riddler, Sharon A; Sinxadi, Phuml... Journal: Clinical infectious diseases Issue: Volume 73:Number 7(2021) Page Start: e2153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir-Containing and Tenofovir-Containing Regimens. (1st July 2021) Authors: Cindi, Zinhle; Maartens, Gary; Bradford, Yuki; Venter, Willem D.F.; Sokhela, Simiso; Chandiwana, Nomathemba C.; Haas, David W.; Sinxadi, Phumla Journal: Journal of acquired immune deficiency syndromes Issue: Volume 87:Number 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus . (4th May 2022) Authors: Cindi, Zinhle; Kawuma, Aida N; Maartens, Gary; Bradford, Yuki; Venter, Francois; Sokhela, Simiso; Chandiwana, Nomathemba; Wasmann, Roeland E; Denti, Paolo; Wiesner, Lubbe; Ritchie, Marylyn D; Haas, David W; Sinxadi, Phumla Journal: Journal of infectious diseases Issue: Volume 226:Number 9(2022) Page Start: 1616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV. Issue 4 (6th June 2023) Authors: Cindi, Zinhle; Kawuma, Aida N.; Maartens, Gary; Bradford, Yuki; Sokhela, Simiso; Chandiwana, Nomathemba; Venter, Willem D. Francois; Wasmann, Roeland E.; Denti, Paolo; Wiesner, Lubbe; Ritchie, Marylyn D.; Haas, David W.; Sinxadi, Phumla Journal: Pharmaocogenetics and genomics Issue: Volume 33:Issue 4(2023) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population. (29th August 2022) Authors: Griesel, Rulan; Sinxadi, Phumla; Kawuma, Aida; Joska, John; Sokhela, Simiso; Akpomiemie, Godspower; Venter, Francois; Denti, Paolo; Haas, David W; Maartens, Gary Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 11(2022) Page Start: 3110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Tenofovir disoproxil and renal mitochondrial toxicity: more studies in Africans are needed. (1st June 2022) Authors: Post, Frank A.; Sinxadi, Phumla Journal: AIDS Issue: Volume 36:Number 7(2022) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗